BrightPoint Revenue Model

The revenue model is based on razors (the hand-held reusable controller) and razor blades (the disposable fiber optic). We are not manufacturing needles (we will seek large needle manufacturers as potential partners).

The BrightPointTM Epidural device is used with existing FDA cleared needles & syringes.

The hand-held controller has an estimated selling price of $1,200 and has a two-year warranty. The disposable, sterile fiber optic has an estimated selling price of $29 (per procedure). The device will be covered under current reimbursement codes for epidural accessories.